CIP
HALO icon

Chartwell Investment Partners’s Halozyme HALO Stock Holding History

Chartwell Investment Partners’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-13,649
Closed -$522K – 429
2023
Q3 		$522K Hold
13,649
– – 0.02% 392
2023
Q2 		$492K Sell
13,649
-10,029
-42% -$342K 0.02% 387
2023
Q1 		$905K Buy
23,678
+6,704
+39% +$314K 0.03% 351
2022
Q4 		$966K Buy
+16,974
New +$869K 0.04% 345

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Chartwell Investment Partners's HALO Position: Q4 2023 in Review

Chartwell Investment Partners sold out of Halozyme (HALO) in Q4 2023, closing a stake of 13,649 shares — an estimated $522K sold.

Chartwell Investment Partners first reported a position in HALO in Q4 2022 and held it in 4 quarters. The position peaked at $966K in Q4 2022. 410 funds tracked by Wall St. Rank hold HALO as of Q4 2023.

  • Chartwell Investment Partners reported no remaining Halozyme position as of Q4 2023 after selling out during the quarter.
  • Chartwell Investment Partners sold 13,649 Halozyme shares in Q4 2023, an estimated $522K.
  • Chartwell Investment Partners first reported a position in Halozyme in Q4 2022 and held it in 4 quarters.
  • Chartwell Investment Partners's Halozyme position peaked at $966K in Q4 2022.
  • 410 funds tracked by Wall St. Rank held Halozyme as of Q4 2023.

Based on Chartwell Investment Partners's 13F filing for Q4 2023, filed 15 Feb 2024.